| 000 | 00896 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516110443.0 | ||
| 264 | 0 | _c20120914 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1207701 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHollander, Judd E | |
| 245 | 0 | 0 |
_aDrotrecogin alfa (activated) in septic shock. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c09 2012 |
||
| 300 |
_a968; author reply 969 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtein C _xtherapeutic use |
| 650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 367 _gno. 10 _gp. 968; author reply 969 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1207701 _zAvailable from publisher's website |
| 999 |
_c22060870 _d22060870 |
||